Archives of Neuroscience

Published by: Kowsar
Crossmark

Assessment of Residual Tumor After Resection of Glioma: A Magnetic Resonance Spectroscopic Study

Samira Raminfard ORCID 1 , 2 , Hamidreza Haghighatkhah 3 , Maysam Alimohamadi 4 , Ali Yoonessi ORCID 1 , Farshid Arbabi 5 , Seyed Amir Hossein Batouli 1 , 2 and Mohammad Oghabian 1 , 6 , *
Authors Information
1 Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
2 Neuro-Imaging and Analysis Group, Tehran University of Medical Sciences, Tehran, Iran
3 Department of Diagnostic Imaging, Shohada‐e‐Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Department of Neurosurgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
5 Department of Radiotherapy, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
6 Department of Medical Physics and Biomedical Engineering, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Archives of Neuroscience: 6 (Special Issue); e88159
  • Published Online: February 5, 2019
  • Article Type: Research Article
  • Received: December 23, 2018
  • Accepted: January 23, 2019
  • DOI: 10.5812/ans.88159

To Cite: Raminfard S , Haghighatkhah H, Alimohamadi M, Yoonessi A, Arbabi F, et al. Assessment of Residual Tumor After Resection of Glioma: A Magnetic Resonance Spectroscopic Study, Arch Neurosci. Online ahead of Print ; 6(Special Issue):e88159. doi: 10.5812/ans.88159.

Abstract
Copyright © 2019, Archives of Neuroscience. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Piepmeier JM, Baehring JM. Brain tumors: Practical guide to diagnosis and treatment. Informa Healthcare; 2007.
  • 2. Ahmed R, Oborski MJ, Hwang M, Lieberman FS, Mountz JM. Malignant gliomas: Current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods. Cancer Manag Res. 2014;6:149-70. doi: 10.2147/CMAR.S54726. [PubMed: 24711712]. [PubMed Central: PMC3969256].
  • 3. McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery. 2008;63(4):700-7. author reply 707-8. doi: 10.1227/01.NEU.0000325729.41085.73. [PubMed: 18981880].
  • 4. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, et al. Extent of resection and survival in glioblastoma multiforme: Identification of and adjustment for bias. Neurosurgery. 2008;62(3):564-76. discussion 564-76. doi: 10.1227/01.neu.0000317304.31579.17. [PubMed: 18425006].
  • 5. Pirzkall A, McGue C, Saraswathy S, Cha S, Liu R, Vandenberg S, et al. Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma. Neuro Oncol. 2009;11(6):842-52. doi: 10.1215/15228517-2009-005. [PubMed: 19229057]. [PubMed Central: PMC2802404].
  • 6. Miles KA. Tumour angiogenesis and its relation to contrast enhancement on computed tomography: A review. Eur J Radiol. 1999;30(3):198-205. doi: 10.1016/S0720-048X(99)00012-1. [PubMed: 10452718].
  • 7. Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology. 2002;59(6):947-9. doi: 10.1212/WNL.59.6.947. [PubMed: 12297589].
  • 8. Price SJ, Gillard JH. Imaging biomarkers of brain tumour margin and tumour invasion. Br J Radiol. 2011;84 Spec No 2:S159-67. doi: 10.1259/bjr/26838774. [PubMed: 22433826]. [PubMed Central: PMC3473903].
  • 9. Fayed N, Olmos S, Morales H, Modrego PJ. Physical basis of magnetic resonance spectroscopy and its application to central nervous system diseases. Am J Appl Sci. 2006;3(5):1836. doi: 10.3844/ajassp.2006.1836.1845.
  • 10. Rae CD. A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra. Neurochem Res. 2014;39(1):1-36. doi: 10.1007/s11064-013-1199-5. [PubMed: 24258018].
  • 11. Aggarwal A, Das PK, Shukla A, Parashar S, Choudhary M, Kumar A, et al. Role of multivoxel intermediate TE 2D CSI MR spectroscopy and 2D echoplanar diffusion imaging in grading of primary glial brain tumours. J Clin Diagn Res. 2017;11(6):TC05-8. doi: 10.7860/JCDR/2017/24982.9984. [PubMed: 28764261]. [PubMed Central: PMC5535451].
  • 12. Pirzkall A, Li X, Oh J, Chang S, Berger MS, Larson DA, et al. 3D MRSI for resected high-grade gliomas before RT: Tumor extent according to metabolic activity in relation to MRI. Int J Radiat Oncol Biol Phys. 2004;59(1):126-37. doi: 10.1016/j.ijrobp.2003.08.023. [PubMed: 15093908].
  • 13. Wilson M, Reynolds G, Kauppinen RA, Arvanitis TN, Peet AC. A constrained least-squares approach to the automated quantitation of in vivo (1)H magnetic resonance spectroscopy data. Magn Reson Med. 2011;65(1):1-12. doi: 10.1002/mrm.22579. [PubMed: 20878762].
  • 14. Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, et al. User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. Neuroimage. 2006;31(3):1116-28. doi: 10.1016/j.neuroimage.2006.01.015. [PubMed: 16545965].
  • 15. Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V. Intraoperative MRI guidance and extent of resection in glioma surgery: A randomised, controlled trial. Lancet Oncol. 2011;12(11):997-1003. doi: 10.1016/S1470-2045(11)70196-6. [PubMed: 21868284].
  • 16. Brown TJ, Brennan MC, Li M, Church EW, Brandmeir NJ, Rakszawski KL, et al. Association of the extent of resection with survival in glioblastoma: A systematic review and meta-analysis. JAMA Oncol. 2016;2(11):1460-9. doi: 10.1001/jamaoncol.2016.1373. [PubMed: 27310651].
  • 17. Roelz R, Strohmaier D, Jabbarli R, Kraeutle R, Egger K, Coenen VA, et al. Residual tumor volume as best outcome predictor in low grade glioma-a nine-years near-randomized survey of surgery vs. biopsy. Sci Rep. 2016;6:32286. doi: 10.1038/srep32286. [PubMed: 27574036]. [PubMed Central: PMC5004168].
  • 18. Parra NA, Maudsley AA, Gupta RK, Ishkanian F, Huang K, Walker GR, et al. Volumetric spectroscopic imaging of glioblastoma multiforme radiation treatment volumes. Int J Radiat Oncol Biol Phys. 2014;90(2):376-84. doi: 10.1016/j.ijrobp.2014.03.049. [PubMed: 25066215]. [PubMed Central: PMC4346247].
  • 19. Jafari-Khouzani K, Loebel F, Bogner W, Rapalino O, Gonzalez GR, Gerstner E, et al. Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients. Neuro Oncol. 2016;18(11):1569-78. doi: 10.1093/neuonc/now100. [PubMed: 27382115]. [PubMed Central: PMC5063518].
  • 20. Pope WB, Sayre J, Perlina A, Villablanca JP, Mischel PS, Cloughesy TF. MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol. 2005;26(10):2466-74. [PubMed: 16286386].
  • 21. Pronin IN, Holodny AI, Petraikin AV. MRI of high-grade glial tumors: Correlation between the degree of contrast enhancement and the volume of surrounding edema. Neuroradiology. 1997;39(5):348-50. doi: 10.1007/s002340050421. [PubMed: 9189880].
  • 22. Ginsberg LE, Fuller GN, Hashmi M, Leeds NE, Schomer DF. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: Histopathological evaluation of a series. Surg Neurol. 1998;49(4):436-40. doi: 10.1016/S0090-3019(97)00360-1. [PubMed: 9537664].
  • 23. Dean BL, Drayer BP, Bird CR, Flom RA, Hodak JA, Coons SW, et al. Gliomas: Classification with MR imaging. Radiology. 1990;174(2):411-5. doi: 10.1148/radiology.174.2.2153310. [PubMed: 2153310].
  • 24. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol. 2003;24(10):1989-98. [PubMed: 14625221].
  • 25. Mauler J, Maudsley AA, Langen KJ, Nikoubashman O, Stoffels G, Sheriff S, et al. Spatial relationship of glioma volume derived from (18)F-FET PET and volumetric MR spectroscopy imaging: A Hybrid PET/MRI study. J Nucl Med. 2018;59(4):603-9. doi: 10.2967/jnumed.117.196709. [PubMed: 28848036]. [PubMed Central: PMC5932747].
  • 26. Gao W, Wang X, Li F, Shi W, Li H, Zeng Q. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: Correlation with the expression of minichromosome maintenance protein 2. Acta Radiol. 2019;60(1):106-12. doi: 10.1177/0284185118770899. [PubMed: 29665708].
  • 27. Pirzkall A, McKnight TR, Graves EE, Carol MP, Sneed PK, Wara WW, et al. MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys. 2001;50(4):915-28. doi: 10.1016/S0360-3016(01)01548-6. [PubMed: 11429219].
  • 28. Guo J, Yao C, Chen H, Zhuang D, Tang W, Ren G, et al. The relationship between Cho/NAA and glioma metabolism: Implementation for margin delineation of cerebral gliomas. Acta Neurochir (Wien). 2012;154(8):1361-70. discussion 1370. doi: 10.1007/s00701-012-1418-x. [PubMed: 22729482]. [PubMed Central: PMC3407558].
  • 29. McKnight TR, von dem Bussche MH, Vigneron DB, Lu Y, Berger MS, McDermott MW, et al. Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg. 2002;97(4):794-802. doi: 10.3171/jns.2002.97.4.0794. [PubMed: 12405365].
  • 30. Zeng QS, Li CF, Zhang K, Liu H, Kang XS, Zhen JH. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. J Neurooncol. 2007;84(1):63-9. doi: 10.1007/s11060-007-9341-3. [PubMed: 17619225].
  • 31. Cha S. Update on brain tumor imaging: From anatomy to physiology. AJNR Am J Neuroradiol. 2006;27(3):475-87. [PubMed: 16551981].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments